These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30479925)

  • 21. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y; Chen H; Shi J
    Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein delivery: from conventional drug delivery carriers to polymeric nanoreactors.
    Balasubramanian V; Onaca O; Enea R; Hughes DW; Palivan CG
    Expert Opin Drug Deliv; 2010 Jan; 7(1):63-78. PubMed ID: 19961359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable sustained-release drug delivery systems: a revolution for ocular therapeutics.
    Cong YY; Fan B; Zhang ZY; Li GY
    Int Ophthalmol; 2023 Jul; 43(7):2575-2588. PubMed ID: 36715956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
    Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
    Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supramolecular Shear-Thinning Glycopeptide Hydrogels for Injectable Enzyme Prodrug Therapy Applications.
    Sakamoto Y; Suehiro F; Akiba I; Nishimura T
    Langmuir; 2022 May; 38(18):5883-5890. PubMed ID: 35471982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and application of pH-responsive drug delivery systems.
    Ding H; Tan P; Fu S; Tian X; Zhang H; Ma X; Gu Z; Luo K
    J Control Release; 2022 Aug; 348():206-238. PubMed ID: 35660634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Progress in Polymeric AIE-Active Drug Delivery Systems: Design and Application.
    Pei Y; Wang Z; Wang C
    Mol Pharm; 2021 Nov; 18(11):3951-3965. PubMed ID: 34585933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sub-100 nm carriers by template polymerization for drug delivery applications.
    Hashim PK; Abdrabou SSMA
    Nanoscale Horiz; 2024 Apr; 9(5):693-707. PubMed ID: 38497369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesoporous carbon nanomaterials in drug delivery and biomedical application.
    Zhao Q; Lin Y; Han N; Li X; Geng H; Wang X; Cui Y; Wang S
    Drug Deliv; 2017; 24(sup1):94-107. PubMed ID: 29124979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel targeted bladder drug-delivery systems: a review.
    Zacchè MM; Srikrishna S; Cardozo L
    Res Rep Urol; 2015; 7():169-78. PubMed ID: 26649286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme-Laden Bioactive Hydrogel for Biocatalytic Monitoring and Regulation.
    Wang X; Wang Q
    Acc Chem Res; 2021 Mar; 54(5):1274-1287. PubMed ID: 33570397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polysaccharide/mesoporous silica nanoparticle-based drug delivery systems: A review.
    Kuang Y; Zhai J; Xiao Q; Zhao S; Li C
    Int J Biol Macromol; 2021 Dec; 193(Pt A):457-473. PubMed ID: 34710474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems.
    Maeki M; Kimura N; Sato Y; Harashima H; Tokeshi M
    Adv Drug Deliv Rev; 2018 Mar; 128():84-100. PubMed ID: 29567396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
    Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.